• MJHLS Brand Logo

© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.

Ovarian Cancer | Tumor

Ovarian Cancer Heroes Award Presentation

October 17th 2020, 10:00pm

Video

Watch the entire Ovarian Cancer Heroes program right here!

CURE®’s Annual Ovarian Cancer Heroes Program Goes Virtual Amid COVID-19 to Honor Three Women Who Have Dedicated Their Lives to Patients with Gynecologic Cancer

October 17th 2020, 1:00pm

Article

An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.

How COVID-19 Robs Patients with Cancer of Their Precious Time

October 6th 2020, 4:00pm

Article

Time is a valuable commodity, especially for patients with cancer who may find themselves with limited time or limited free time to enjoy the things they loved prior to their cancer. But the COVID-19 pandemic is robbing patients of that precious time.

Long-Term Evidence Confirms Benefit of Approved Lynparza Maintenance Strategy in Advanced Ovarian Cancer

September 29th 2020, 7:00pm

Article

Five-year follow-up data from the phase 3 SOLO-1 trial demonstrates a nearly five-year delay in disease progression with Lynparza compared with a delay of just over a year with placebo in women with newly diagnosed, advanced ovarian cancer harboring a BRCA gene mutation.

Dose-Dense Chemo Regimen No Better Than Standard of Care for Epithelial Ovarian Cancer

September 28th 2020, 6:00pm

Article

A weekly high dose of chemotherapy did not improve survival for patients with epithelial ovarian cancer, though the treatment regimen was effective and well-tolerated.

Study Finds Premenopausal Women Facing Increased Ovarian Cancer Risk Favor Removing Fallopian Tubes But Save Ovaries

September 11th 2020, 9:00pm

Article

A proposed preventive surgery that would take out fallopian tubes before menopause but save ovary removal until afterwards was favored by most premenopausal previvors of ovarian cancer in a study.

Patients with Ovarian Cancer Suggest Using Visual Learning Aids and Simplified Language to Better Help Them Understand Genetic Testing and Counseling

September 11th 2020, 6:00pm

Article

The study results also showed that older age was significantly associated with lower cancer genetics knowledge, which, according to a post-doctoral research fellow at Dana-Farber Cancer Institute, is important because older adults may serve as a resource for family members who seek information about their family's health history.

Mektovi Fails to Improve Progression-Free Survival in Rare Ovarian Cancer Subset, But Shows Effective Results

September 10th 2020, 9:00pm

Article

Compared to physician’s choice of chemotherapy, the MEK inhibitor Mektovi failed to improve progression-free survival in patients with low-grade serous ovarian carcinomas. However, the study authors note Mektovi demonstrated promising results that support continued use of the treatment.

National Ovarian Cancer Coalition to Host Annual Together in Teal® Event

September 8th 2020, 3:54pm

Article

The National Ovarian Cancer Coalition to host its annual "Together in Teal®" No Boundaries National Broadcast Celebration During September awareness month on Saturday, Septemeber 26, 2020.

Lynparza Maintenance Delays Disease Progression for Advanced BRCA-Positive Ovarian Cancer

September 3rd 2020, 6:00pm

Article

Immediate treatment with Lynparza after standard surgery and chemotherapy should be considered for all patients with newly diagnosed stage 3 or 4 ovarian cancer that carries a BRCA gene mutation, even if residual disease remains, researchers have found.

x